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SUMMARY

The entry of human immunodeficiency virus (HIV-1)
into cells is initiated by binding of the gp120 exterior
envelope glycoprotein to the receptor, CD4. How
does CD4 binding trigger conformational changes
in gp120 that allow the gp41 transmembrane envelope glycoprotein to mediate viral-cell membrane
fusion? The transition from the unliganded to the
CD4-bound state is regulated by two potentially flexible topological layers (layers 1 and 2) in the gp120
inner domain. Both layers apparently contribute to
the noncovalent association of unliganded gp120
with gp41. After CD4 makes initial contact with the
gp120 outer domain, layer 1-layer 2 interactions
strengthen gp120-CD4 binding by reducing the off
rate. Layer 1-layer 2 interactions also destabilize the
activated state induced on HIV-1 by treatment with
soluble CD4. Thus, despite lack of contact with CD4,
the gp120 inner-domain layers govern CD4 triggering
by participating in conformational transitions within
gp120 and regulating the interaction with gp41.

INTRODUCTION
Human immunodeficiency virus (HIV-1) entry into the host cell is
mediated by the viral envelope glycoproteins (Env gps), which
are derived by proteolytic cleavage of a trimeric, glycosylated
gp160 Env gp precursor (Allan et al., 1985; Robey et al., 1985).
The resulting mature Env gps, gp120 (SU) and gp41 (TM), constitute a trimeric complex that is anchored on the virion surface by
the membrane-spanning segments of gp41 (Chan et al., 1997;
Weissenhorn et al., 1997; Farzan et al., 1998; Zhu et al., 2003).
The gp120 exterior Env gp is retained on the trimer via labile,
noncovalent interactions with the gp41 ectodomain (Helseth
et al., 1991). The gp120 glycoprotein binds the initial receptor,
CD4 (Dalgleish et al., 1984; Klatzmann et al., 1984). CD4 binding
triggers conformational changes in gp120 that promote its interaction with one of the chemokine receptors, CCR5 or CXCR4
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(Alkhatib et al., 1996; Choe et al., 1996; Deng et al., 1996; Doranz
et al., 1996; Dragic et al., 1996; Feng et al., 1996; Trkola et al.,
1996; Wu et al., 1996). CD4 binding also induces conformational
changes within the HIV-1 Env gp trimer that result in the exposure of a helical heptad repeat (HR1) segment of the gp41 ectodomain (Furuta et al., 1998; He et al., 2003; Koshiba and Chan,
2003; Si et al., 2004). Eventually, the conformational transition
of the gp41 ectodomain from the CD4-induced ‘‘prehairpin intermediate’’ into a six-helix bundle composed of the HR1 and HR2
heptad repeat regions results in the fusion of the viral and target
cell membranes (Lu et al., 1995; Chan et al., 1997; Weissenhorn
et al., 1997).
The HIV-1 Env gps serve as a prototype for viral envelope
proteins that are activated to mediate virus entry by engagement
of the receptors. The energy required for viral-cell membrane
fusion derives from the sequential transitions that the HIV-1
Env gps undergo, from the high-energy unliganded state to the
low-energy six-helix bundle. The graded transitions down this
energetic slope are initially triggered by CD4 binding. Thermodynamic, mutagenic, and structural studies have provided insights
into the HIV-1 gp120-CD4 interaction. The gp120 glycoprotein is
composed of two domains: a gp41-interactive inner domain
and a heavily glycosylated outer domain (Kwong et al., 1998).
In the CD4-bound state, a bridging sheet minidomain connects
the inner and outer domains (Kwong et al., 1998). CD4 initially
binds a highly conserved region on the surface of the gp120
outer domain (Zhou et al., 2007). The interaction of gp120 and
CD4 is accompanied by an unusually large, favorable enthalpic
change, which offsets a large unfavorable change in entropy
(Myszka et al., 2000). Certain antibodies and small molecules
bind HIV-1 gp120 with similar thermodynamic signatures
(Kwong et al., 2002; Schön et al., 2006). The binding of these
ligands is thought to introduce order into the conformationally
flexible unliganded gp120, accounting for the entropy decrease.
The refolding of gp120 elements upon CD4 binding, which
involves the formation of numerous internal bonds in gp120,
contributes to the large change in enthalpy and to the slow off
rate of bound CD4 (Myszka et al., 2000; Kwong et al., 2002;
Kassa et al., 2009).
Structural studies have revealed the contacts between HIV-1
gp120 and CD4 (Kwong et al., 1998). Several bridging sheet
and outer domain gp120 residues that are highly conserved
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among HIV-1 strains contact CD4 residues phenylalanine 43 and
arginine 59, contributing much of the binding energy of the
gp120-CD4 interaction. Binding CD4 creates the ‘‘Phe 43
cavity,’’ an interfacial cavity bound by all three gp120 domains
and by phenylalanine 43 of CD4. The walls of the Phe 43 cavity
are lined by well-conserved gp120 residues, rendering it suitable
as a target for small-molecule inhibitors (Madani et al., 2008).
Interventional approaches targeting the CD4-binding site, using
either antibodies or small molecules, would benefit from a better
understanding of the conformational transitions involved in
receptor binding.
In previous structural studies (Kwong et al., 1998; Chen et al.,
2005; Zhou et al., 2007), the N and C termini of gp120, which
contribute to the noncovalent association with gp41 (Helseth
et al., 1991; Binley et al., 2000), were truncated to facilitate crystallization. Recently, the structure of an HIV-1 gp120 variant with
intact termini, bound to soluble CD4 and a neutralizing antibody
fragment, has been solved (Pancera et al., 2010). This structure
reveals the complete gp41-interactive region of gp120 in the
CD4-bound conformation. The N- and C-terminal strands of
gp120 project from the inner domain toward the viral membrane,
presumably contacting the gp41 ectodomain. The inner domain,
revealed in its entirety for the first time, can be subdivided into
two parts: (1) a b sandwich, which mutagenesis studies suggest
contributes to gp41 association (Helseth et al., 1991; Yang et al.,
2003), and (2) three loops that emanate from the strands of the
b sandwich and project toward the target cell. These loops
form three topological layers that, like the leaves of a book,
have been proposed to exhibit conformational flexibility; such
flexibility would presumably contribute to the high entropy of
the unliganded HIV-1 gp120 and allow transitions to the CD4bound conformation. Here, we investigate the role of these
inner-domain layers in HIV-1 entry.
RESULTS
The HIV-1 gp120 Inner-Domain Mutants
A recent X-ray crystallographic analysis of CD4-bound HIV-1
gp120 with intact N and C termini has revealed the structure of
the complete gp120 inner domain (Pancera et al., 2010) (Figure 1A). A key component of the inner domain, a seven-stranded
b sandwich, serves as a point of departure for the gp120 N and C
termini, which meander toward the viral membrane. The b sandwich and the gp120 terminal strands have been implicated in the
noncovalent association of gp120 with gp41 (Helseth et al.,
1991; Binley et al., 2000; Yang et al., 2003; Sen et al., 2008;
Wang et al., 2008). Projecting from the b sandwich toward the
target cell membrane are three excursions that compose the
rest of the inner domain and, in two cases, transit into neighboring domains. These excursions form three topological layers
(layers 1, 2, and 3) that have been proposed to change conformation as gp120 undergoes the transition from the unliganded
to the CD4-bound state (Pancera et al., 2010). To test this
hypothesis, single amino acid changes were introduced into
the Env gps of HIV-1YU2, a primary virus directly cloned from
an HIV-1-infected individual (Li et al., 1992). The changes were
focused on layers 1 and 2, although a few alterations were introduced into adjacent gp120 structures.

The Env gp mutants were evaluated with respect to the
following properties: proteolytic processing of the gp160
precursor, association of the gp120 and gp41 subunits, CD4
binding, functional ability to mediate cell-cell fusion and virus
entry, and the effect of soluble CD4 (sCD4) on virus infectivity
(Table 1). The conformation of gp120 in cell supernatants was
assessed in two ways: (1) analysis on nonreducing SDS-polyacrylamide gels that allowed detection of aberrant, disulfidelinked dimers indicative of inefficient folding and (2) precipitation
by a panel of monoclonal antibodies that recognize conformation-dependent epitopes (Moore and Sodroski, 1996; Table S1
available online). The L52A, F53A, M100A, and I215A mutants
exhibited evidence of significant conformational disruption and
were not considered further.
The Ability of Mutant Env gps to Bind CD4
The effects of the changes introduced into the inner domain
on the affinity of gp120 for CD4 were examined. Comparable
amounts of radiolabeled gp120 in the supernatants of 293T cells
expressing the Env gps were incubated with CD4-Ig. CD4-Ig is a
fusion protein in which the N-terminal two domains of CD4 are
linked to the Fc component of immunoglobulin G (Chowdhury
et al., 1991). Three sets of changes decreased the efficiency
with which mutant gp120s were precipitated by CD4-Ig. The first
set of changes involved residues (H66, W69, L111, F210, and
P212) at the interface of layer 1 and layer 2 (Figure 1B and Table
S2). These mutants exhibited moderate decreases in the efficiency with which they were precipitated by CD4-Ig (Figure 2A
and Table 1). The observed decreases in CD4 binding were
mainly due to the increased off rates of the mutants compared
with that of wild-type (WT) gp120 (Table 2). Thus, gp120 mutants
with alterations in the layer 1-layer 2 interface fail to retain CD4
tightly upon initial binding.
A second set of changes involving W112, I109, and L116
in layer 2 resulted in reductions in CD4 binding (Figure 2B
and Table 1). Although W112 does not contact CD4, it lines
the Phe 43 cavity and, along with I109, interacts with W427, a
cavity-lining residue that does contact CD4 (Lasky et al., 1987;
Olshevsky et al., 1990; Kwong et al., 1998; Wyatt et al., 1998).
Trp112 and L116 interact with F382, which also abuts the Phe
43 cavity. Thus, a network of interactions involving the distal
end of the a1 helix in gp120 layer 2 contributes to CD4 binding.
Finally, alteration of D107 or Y217, which interact with each
other within layer 2 (Figure 1B), decreased CD4-binding affinity
(Tables 1 and 2). Thus, multiple inner-domain residues that do
not contact CD4 nonetheless contribute to the affinity of the
gp120-CD4 interaction.
Effect of Filling the Phe 43 Cavity on the Phenotypes
of Inner-Domain Mutants
Serine 375 flanks the Phe 43 cavity; substitution of a tryptophan
residue for S375 fills the Phe 43 cavity with the indole ring
(Zhou et al., 2007). As a result, the S375W mutant favors conformation(s) closer to that of the CD4-bound state (Xiang et al., 2002). To
determine whether such a change in gp120 conformation would
influence the phenotypes of the inner-domain mutants, we introduced the S375W change into some of the gp120 variants
described above. Remarkably, the presence of the S375W change
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Figure 1. Structure of the Inner Domain of HIV-1 gp120 in the CD4-Bound Conformation
(A) The structure (Pancera et al., 2010) of HIV-1HXBc2 gp120 (ribbon) complexed with two-domain CD4 (pink molecular surface) is shown from the approximate
perspective of the Env gp trimer axis. The outer domain of gp120 is colored yellow. The N and C termini are colored cyan. The components of the gp120 inner
domain are the b sandwich (red) and three loop-like extensions: layer 1 (magenta), layer 2 (green), and layer 3 (orange). The b20-b21 strands of gp120 (blue)
project from the outer domain and, in the CD4-bound conformation, compose two of the strands of the four-stranded bridging sheet. The other two strands
of the bridging sheet are derived from the distal portion of layer 2.
(B) A close-up view of the interactions of layer 2 (green) with layer 1 (magenta) and with the b20-b21 loop (blue) is shown from the same perspective as in (A).
The surface of CD4 (pink) is visible in the upper-right corner of the image.
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completely restored the CD4-binding abilities of the gp120
mutants with alterations in H66, W69, and L111 (Table 2). In fact,
the affinities of the W69L/S375W and L111A/S375W gp120 glycoproteins for sCD4 were greater than that of WT gp120. Thus, filling
the Phe 43 cavity with the hydrophobic tryptophan side chain
compensates for deficient layer 1/layer 2 contributions to the
conformational transition of gp120 to the CD4-bound state.
Recognition of Mutants by Ligands that Prefer
the CD4-Bound Conformation
We examined the binding of some of the inner-domain gp120
mutants by ligands, CD4-induced (CD4i) antibodies and CCR5,
that preferentially recognize the CD4-bound conformation
(Trkola et al., 1996; Wu et al., 1996; Thali et al., 1993). These
ligands bind overlapping, conserved regions on gp120 (Kwong
et al., 1998; Wyatt and Sodroski, 1998).
In the absence of sCD4, the W69L, D107A, and L111A
changes in the inner domain reduced CCR5 binding 2-fold
compared with that of the WT gp120 (Figure 2C). The S375W
change that fills the Phe 43 cavity increased CCR5 binding of
WT gp120 in the absence of sCD4, as expected (Xiang et al.,
2002); however, the S375W change did not fully compensate
for the diminished CCR5-binding ability of the W69L, D107A,
and L111A mutants. Addition of sCD4 partially restored the
CCR5-binding ability of the L111A mutant, but not of the other
mutants (Figure 2D). Thus, alteration of layer 1 or 2 residues in
the gp120 inner domain moderately decreased CCR5 binding
in a manner that was not completely compensated by the
S375W change or by sCD4 binding.
The W69L, D107A, and L111A mutants were precipitated by
the 17b and 412d CD4i antibodies less efficiently than WT
gp120 (Table 2 and Figure S1). Significant reductions in on rates
contributed to the decrease in 17b affinity (Table 2), indicating
that these mutants do not spontaneously sample the conformation recognized by the 17b antibody as efficiently as WT gp120.
Precipitation of the mutants by the 17b and 412d antibodies was
enhanced by the S375W change but was not restored to WT
gp120 levels. However, incubation with sCD4 restored efficient
17b binding to all of the mutants (Table 2), indicating that these
inner domain alterations do not directly disrupt the 17b epitope.
Thus, layer 1 and layer 2 in the inner domain contribute to the
ability of HIV-1 gp120 to assume spontaneously the conformation preferred by CD4i antibodies.
Proteolytic Processing and Subunit Association
of the Env Glycoprotein Mutants
Proteolytic processing of the gp160 precursor and association
of the gp120 and gp41 subunits of each mutant Env gp were
evaluated. All of the mutants were expressed efficiently,

although a few mutants exhibited decreases in proteolytic processing of the gp160 Env gp precursor (Table 1). Several mutant
Env gps exhibited a decrease in the noncovalent association of
the gp120 and gp41 subunits (Table 1 and Figure 1C). These
mutants contained alterations in three gp120 regions:
(1) The inner domain b sandwich: This structure has been
previously implicated in gp120-gp41 interactions (Yang et al.,
2003).
(2) Layer 1: Changes in A72 and H73 resulted in significant
decreases in the association of gp120 and gp41. However,
somewhat unexpectedly, given the predicted location of layer
1 near the trimer axis, most changes in layer 1 residues resulted
in only modest reductions in gp120-gp41 association.
(3) Layer 2: Changes in several layer 2 residues, particularly
those located in the distal end of the a1 helix, significantly
disrupted gp120-gp41 association. One of these layer 2 residues
(L111) is involved in interactions with layer 1 in the CD4-bound
conformation (Figure 1B); of note, changes in the cognate
interacting residues (H66 and W69) in layer 1 did not significantly
decrease gp120-gp41 association. This suggests that the layer
1-layer 2 interactions that occur in the CD4-bound conformation
of gp120 are not absolutely required for gp41 association in the
unliganded Env glycoproteins. Most of the layer 2 residues implicated in gp120-gp41 association are not solvent accessible in
the CD4-bound conformation (Figure 1D). Thus, elements of
gp120 layer 2 that are relatively buried in the CD4-bound conformation apparently contribute, either directly or indirectly, to the
noncovalent association with gp41 in the unliganded HIV-1 Env
glycoproteins.
Function of the Mutant HIV-1 Env gps
The mutant HIV-1 Env gps were assessed for the ability to
mediate cell-cell fusion and to support virus entry into cells
expressing CD4 and CCR5. In both assays, most of the mutant
Env gps exhibited detectable activity (Table 1). The mutant
Env gps with the lowest gp120-gp41 association indices also
exhibited the lowest activities in these functional assays.
A number of mutant Env gps with changes in layer 1 (W69, T71,
H72, D78, and P79) and layer 2 (Q103, D107, I109, S110, L111,
W112, Q114, F210, I213, Y217, and A221) mediated cell-cell
fusion much more efficiently than cell-free virus infectivity. This
phenotype has previously been observed for alterations in the
inner-domain b sandwich (Yang et al., 2003). Most of these
mutants exhibited reductions in the efficiency of gp120-gp41
subunit association. Because the time between Env gp
synthesis and engagement of the target cell is much longer in
the virion infectivity assay than in the cell-cell fusion assay, the
former assay is more sensitive to decreases in gp120/gp41
stability.

(C) The center image is a ribbon diagram of the CD4-bound HIV-1 gp120 glycoprotein, shown in the same orientation as that in (A). The ribbon and side-chain
residues that were altered in this and a previous study (Yang et al., 2003) are colored according to the gp120-gp41 association index (red, association index < 0.5;
orange, 0.5 % association index < 0.7; green, association index R 0.7). In the left and right images, layer 1 and layer 2 are separated from the rest of the
gp120 glycoprotein. The disulfide bond in layer 1 between cysteines 54 and 74 is colored yellow.
(D) The gp120 glycoprotein in the CD4-bound conformation is shown from the perspective in (A). In the left image, on the Ca trace of gp120, the atoms of layer
2 residues with association indices less than 0.5 are colored red; residues with association indices between 0.5 and 0.7 are colored orange. The image at the right
shows the solvent-accessible surface of gp120, colored similarly.
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Table 1. Characterization of HIV-1YU2 gp120 Inner-Domain Mutants
Envelope
Glycoprotein

CD4-Ig
Bindinga

Cell-Cell
Fusiona

Relative
Infectivitya

sCD4
IC90 (nM)a

Processing
Indexa
1.00

1.00

1.00

1.00

1.00

90

b3 strand

0.49

0.64

nd

nd

nd

nd

Wild-type YU2
E47A

Association
Indexa

Residue
Location

T49A

layer 1

0.77

1.07

1.14

0.96

1.06

90

T51A

layer 1

0.69

1.06

1.02

0.85

0.89

nd

L52A

layer 1

0.36

0.25

0.23

0.1

0.01

nd

F53A

layer 1

0.40

0.25

0.29

0.39

0.02

nd

D57A

layer 1

0.65

0.62

0.91

0.86

0.54

nd

A60G

layer 1

0.92

0.86

1.46

0.89

0.79

nd

Y61A

layer 1

0.95

0.89

1.33

0.81

0.74

nd

T63A

layer 1

0.98

0.99

1.79

0.43

1.11

nd

H66A

layer 1

1.08

0.97

0.50

0.82

0.88

200

V68A

layer 1

1.07

0.60

1.12

0.51

0.68

nd

W69L

layer 1

0.88

0.89

0.64

1.07

0.33

>400

T71A

layer 1

0.79

0.58

0.85

0.92

0.03

nd

H72A

layer 1

1.02

0.33

1.11

0.56

0.04

nd

A73S

layer 1

1.13

0.46

1.19

0.32

0.86

nd

V75A

layer 1

0.75

0.55

0.72

0.40

0.19

nd

P76A

layer 1

0.85

0.64

1.02

0.37

0.11

nd

T77A

layer 1

1.66

0.56

1.52

0.95

0.65

90

D78A

layer 1

0.69

0.51

1.13

1.03

0.11

90

P79A

layer 1

1.09

0.64

1.29

0.90

0.54

88

N80A

layer 1

1.21

0.65

1.24

0.97

0.99

90

P81A

layer 1

1.18

0.61

1.10

0.89

0.81

90

Q82A

layer 1

1.17

1.03

1.12

0.92

0.98

100

E83A

b sandwich

0.93

0.61

0.86

0.63

0.29

70

L86A

b sandwich

0.65

0.36

0.48

0.58

0.07

20

V89A

b sandwich

0.56

0.22

0.97

0.57

0.01

nd

T90A

b sandwich

0.65

0.55

1.27

0.85

0.87

20

1.45

0.26

0.07

80

nd

0.01

<0.01

nd

E91A

b sandwich

0.53

0.41

F93A

b sandwich

0.37

<0.01

W96A

layer 2

1.35

0.65

0.66

2.79

0.96

110

K97A

layer 2

1.32

0.93

0.93

0.57

0.98

110

N99A

layer 2

1.18

0.70

0.97

1.28

0.82

nd

M100A

layer 2

0.75

0.29

0.50

0.75

0.39

nd

E102A

layer 2

1.36

0.79

0.81

0.83

1.03

50

Q103A

layer 2

0.77

1.07

1.15

nd

0.79

60

Q103R

layer 2

0.86

0.33

0.74

1.59

0.18

20

M104A

layer 2

1.38

0.47

1.25

nd

0.21

90

E106A

layer 2

0.86

0.61

0.90

0.59

0.58

nd

D107A

layer 2

0.24

0.32

0.66

0.39

0.09

20

D107Q

layer 2

0.78

0.61

0.69

0.79

0.01

nd

D107Y

layer 2

0.14

0.31

nd

0.62

<0.01

nd

I108A

layer 2

0.68

0.79

1.48

nd

0.43

300

I109A

layer 2

0.95

0.44

0.49

1.95

0.41

50

I109W

layer 2

0.96

0.39

0.35

2.40

0.34

200

S110A

layer 2

0.69

0.62

0.83

1.04

0.09

90

S110N

layer 2

0.73

0.66

nd

1.09

0.21

90

S110W

layer 2

0.59

0.49

nd

0.98

0.03

20
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Table 1. Continued
Envelope
Glycoprotein

Residue
Location

Processing
Indexa

Association
Indexa

CD4-Ig
Bindinga

Cell-Cell
Fusiona

Relative
Infectivitya

sCD4
IC90 (nM)a

L111A

layer 2

0.34

0.28

0.48

0.72

0.04

>400

L111F

layer 2

0.32

0.10

0.75

0.46

0.02

20

W112A

layer 2

1.07

0.17

0.25

0.98

0.07

100

D113A

layer 2

1.08

0.55

1.79

nd

0.50

30

Q114N

layer 2

0.93

0.74

1.09

1.78

0.42

50

S115A

layer 2

0.98

1.12

1.36

nd

0.79

150

L116A

layer 2

1.04

0.25

0.67

0.25

<0.01

nd

F210A

layer 2

0.51

1.33

0.56

0.85

0.06

40

P212A

layer 2

0.88

0.93

0.65

1.85

0.76

360

I213A

layer 2

0.37

0.48

0.62

0.92

0.04

160

I215A

layer 2

0.34

0.45

0.46

0.85

0.01

80

Y217A

layer 2

0.60

0.32

0.52

0.67

0.15

nd

A221G

layer 2

1.02

0.43

0.76

1.04

0.01

nd

F223A

b sandwich

0.90

0.23

0.85

0.63

0.19

nd

S375W

Phe 43 cavity

0.82

0.93

1.12

0.69

0.70

20

W437R

b20-b21 loop

1.07

0.64

0.09

0.46

<0.01

nd

K487A

b25 strand

0.13

0.3

nd

nd

nd

nd

K487E

b25 strand

0.13

0.2

nd

nd

nd

nd

W69L/L111W

layer 1/layer 2

0.62

0.28

0.72

0.30

0.02

140

H66A/S375W

layer 1/Phe 43

0.84

0.95

1.10

0.75

0.42

20

W69L/S375W

layer 1/Phe 43

0.88

0.81

1.11

1.09

0.28

20

D107A/S375W

layer 2/Phe 43

0.12

0.61

0.76

0.61

L111A/S375W

layer 2/Phe 43

0.62

<0.01

1.32

0.34

nd
0.03

nd
20

Results represent the mean values derived from at least three experiments. Less than 20% deviation from the mean value was typically observed. nd,
not determined.
a
The phenotypes of the WT and mutant Env gps were determined as described in the Experimental Procedures.

Sensitivity of the Mutant Viruses to Neutralization
by sCD4
Changes in CD4-binding affinity can result in altered HIV-1 sensitivity to sCD4-mediated neutralization (Thali et al., 1991). Several
viruses bearing Env gps with alterations in layer 1 (H66A and

W69L) or layer 2 (I108A, I109W, L111A, S115A, P212A, and
I213A) were more resistant to sCD4 than viruses with WT Env
gps (Figure 3A and Table 1). The introduction of the S375W
change, which fills the Phe43 cavity (Xiang et al., 2002; Zhou
et al., 2007), into the H66A, W69L, and L111A mutant Env gps
Figure 2. Binding of gp120 Receptors
(A and B) The effects of alterations in the layer
1-layer 2 interface (A) or in layer 2 (B) on gp120
recognition by CD4-Ig were examined. Normalized
amounts of radiolabeled wild-type mutant gp120
glycoproteins were incubated with increasing
concentrations of CD4-Ig for 2 hr at 37 C. The
precipitates were washed, run on SDS-polyacrylamide gels, and analyzed by densitometry. All
values were normalized to a saturating value for
the WT gp120. Representative results from at least
two independent experiments are shown.
(C and D) Similar amounts of radiolabeled gp120
glycoproteins were incubated in the absence (C) or
presence (D) of 200 nM sCD4 prior to addition to cells
expressing CCR5. After 2 hr at 37 C, the amount of
bound mutant gp120 was determined and normalized to the observed amount of bound WT gp120.
Incubation with sCD4 increased the binding of
WT gp120 8-fold. The data shown represent the
means ± SEM of two independent experiments.
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1.92 3 10
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The gp120-reactive ligand (sCD4 or 17b) was immobilized directly onto a CM5 sensor chip, and the binding of the indicated gp120 gps was evaluated as described in the Experimental
Procedures.
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gp120 Variant

Wild-type

7

Off-Rate
KD (M)
On-Rate
Constant (M 1s 1) Constant (s 1) (Fold Change)

4

17b (+ sCD4)

On-Rate
Off-Rate
KD(M) (Fold
Constant (M 1s 1) Constant (s 1) Change)

17b

On-Rate
Off-Rate
KD(M) (Fold
Constant (M 1s 1) Constant (s 1) Change)

sCD4

Table 2. Characterization of Ligand Binding to Selected HIV-1YU2 gp120 Mutants by Surface Plasmon Resonance

3

(1.0)

HIV-1 gp120 Inner Domain Governs CD4 Triggering

662 Molecular Cell 37, 656–667, March 12, 2010 ª2010 Elsevier Inc.

resulted in viruses that were neutralized by sCD4 as efficiently as
a virus with WT Env gps (Figure 3B and Table 1).
We also introduced a compensatory change (L111W) in layer 2
that modeling suggested might restore interaction with the W69L
mutant, which has an alteration of layer 1. The sensitivity of this
mutant to sCD4 increased considerably compared with that of
the W69L mutant virus (Figure 3C), even though the W69L/
L111W mutant did not completely regain the ability to bind
CD4 (Tables 1 and 2 and data not shown). Other instances
(e.g., I108A and S115A) were observed in which altered sensitivity to sCD4 was not explained by CD4-Ig binding to gp120
monomers (Table 1). Thus, changes in the gp120 inner domain
may specifically affect sCD4 binding to the Env gp trimer or
may modulate the inhibitory consequences of sCD4 binding on
HIV-1 infectivity (see below).
An extreme consequence of sCD4 binding is the shedding of
gp120 from the Env gp trimer (Moore et al., 1990; Hart et al.,
1991; Thali et al., 1992). The H66A and W69L mutants exhibited
less sCD4-induced gp120 shedding than did the WT Env gps
(Figure 3D). The S375W change restored the efficiency of
sCD4-induced gp120 shedding in the H66A and W69L mutant
Env gps to levels near that of the WT Env gps (Figure 3E).
Thus, for this group of mutants, sCD4 binding to gp120, sCD4
induction of gp120 shedding, and sCD4 inhibition of HIV-1 infection correlate.
Infection of CD4-Negative Cells by Viruses
with Mutant Env gps
Soluble CD4 induces a transient activated state in the HIV-1 Env
gps (Haim et al., 2009). To examine the effect of layer 1 changes
on this process, recombinant viruses bearing WT or mutant Env
gps were incubated with CD4-negative, CCR5-expressing
Cf2Th cells along with different concentrations of sCD4. In the
absence of sCD4, no infection by any of the viruses was detected (Figures 4A and 4B). The addition of a low concentration
(20 nM) of sCD4 resulted in a slight increase in infectivity for
viruses bearing the WT Env gps; this low level of infectivity was
not observed at high concentrations (R100 nM) of sCD4.
Of interest, recombinant viruses bearing the H66A and W69L
Env gps exhibited greater enhancement of infectivity by sCD4
than did their WT counterpart (Figures 4A and 4B). For these
mutant viruses, the enhancement of infection was evident at
high sCD4 concentrations (R100 nM). Also of interest, the infectivity of viruses bearing the S375W Env glycoproteins was minimally enhanced and only at a low concentration of sCD4; this is
consistent with other studies suggesting that the CD4-bound
conformation of HIV-1, which is favored by the S375W Env gps
(Xiang et al., 2002; Zhou et al., 2007), is more prone to rapid
inactivation (Haim et al., 2009; Kassa et al., 2009). Remarkably,
introduction of the S375W change together with the W69L or
H66A changes resulted in viruses that exhibited an enhancement
of infectivity at low concentrations of sCD4 and retained significant infectivity at high concentrations of sCD4 (Figures 4A and
4B). Similar results were observed when the T257S change
was introduced along with the S375W change into the W69L
and H66A mutants (Figure S2); the T257S change allows better
accommodation of the tryptophan side chain in the Phe 43 cavity
(Zhou et al., 2007). These double mutants apparently bind sCD4
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comparably to viruses with the wild-type Env gps because they
are activated more efficiently at low sCD4 concentrations; moreover, for infection of cells expressing CD4 and CCR5, the double
mutants were neutralized by sCD4 as efficiently as viruses with
wild-type Env gps (Figures 3B and S2). Thus, although viruses
bearing the H66A/S375W and W69L/S375W Env gps interact
efficiently with sCD4, they are less susceptible than wild-type
viruses to inactivation at higher sCD4 doses.
DISCUSSION

Figure 3. Sensitivity of HIV-1 Env gp Variants to Soluble CD4
(A–C) Recombinant HIV-1 expressing luciferase and bearing WT or mutant
HIV-1 Env gps were normalized by reverse transcriptase activity. Equal
amounts of viruses were incubated with serial dilutions of soluble CD4 (sCD4)
at 37 C for 1 hr prior to infection of Cf2Th-CD4/CCR5 cells. Infectivity at each
dilution of sCD4 tested is shown as the percent of infection without sCD4 for
each particular mutant. Duplicate samples were analyzed; data shown are
representative of those obtained in at least three independent experiments.
(D and E) The sCD4-induced shedding of gp120 from HIV-1 Env gps expressed on the cell surface was measured. Transfected 293T cells were metabolically labeled with [35S]-methionine/cysteine for 16 hr in the presence of

Guided by a new crystal structure that includes the complete
gp41-interactive region of the CD4-bound HIV-1 gp120 (Pancera
et al., 2010), we identified a network of interactions involving the
gp120 inner domain that modulate gp120-gp41 association,
CD4-binding affinity, and susceptibility to inactivation by sCD4.
Prior to receptor engagement, gp120 must maintain its noncovalent association with gp41 and prevent gp41 from prematurely
undergoing transitions to lower-energy conformations. In both
unliganded and CD4-bound states, two HIV-1 gp120 elements,
a seven-stranded b sandwich and the N- and C-terminal extensions from this sandwich, play a major role in mediating gp120gp41 association (Helseth et al., 1991; Binley et al., 2000; Yang
et al., 2003; Sen et al., 2008; Wang et al., 2008). Two other
gp120 regions apparently contribute to the interaction with
gp41 in the unliganded Env gp trimer. The first region involves
layer 1, which is predicted to reside near the trimeric axis of
the Env gp complex (Kwong et al., 2000; Pancera et al., 2010)
and thus would be well positioned to interact with gp41. Indeed,
changes in two layer 1 residues (H72 and A73) did decrease
subunit association. Unexpectedly, however, most changes in
layer 1 residues (including those interacting with layer 2) exerted
modest or no effects on gp120-gp41 association. Thus, layer 1
may play a modulatory rather than a primary role in the gp120gp41 interaction. Such a role has been suggested for valine 65
in the layer 1 a0 helix, based on the coselection of gp120 and
gp41 changes during virus adaptation to T cell lines (Leavitt
et al., 2003).
A second region that is important for gp120-gp41 association
is layer 2, particularly the distal end of the a1 helix. Most of these
layer 2 mutants mediate cell-cell fusion efficiently and are recognized by conformation-dependent antibodies and, thus, are not
globally misfolded. Many of the layer 2 residues implicated in
gp120-gp41 association are not surface exposed in the CD4bound conformation of gp120. Thus, any direct interaction
between these layer 2 residues and gp41 would require the existence of a different gp120 conformation in the unliganded state.
Other studies have suggested the possibility that the distal
elements of layer 2 and the adjacent b2-b3 strands, which
compose part of the bridging sheet, undergo conformational
changes upon CD4 binding (Kwong et al., 1998; Chen et al.,
2005; Pan et al., 2005; Rits-Volloch et al., 2006). Indeed, in some
structures of gp120 without CD4 (Chen et al., 2005; Zhou et al.,
increasing concentrations of sCD4 (0–200 nM). Cell lysates were precipitated
with a mixture of sera from HIV-1-infected individuals. Precipitates were
analyzed by SDS-PAGE, autoradiography, and densitometry. Data shown
represent the means ± SEM obtained from two independent experiments.
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Figure 4. Effect of Soluble CD4 on HIV-1 Infection of CD4-Negative, CCR5-Expressing Cells
(A and B) Recombinant luciferase-expressing HIV-1 with the indicated HIV-1 Env gps were normalized by reverse transcriptase activity and incubated with serial
dilutions of sCD4 at 37 C for 1 hr prior to infection of Cf2Th-CCR5 cells. The level of infection is reported as relative light units (RLU). For each data point, the
infection was performed in duplicate; data shown represent the means ± SEM derived from two independent experiments.

2007; Chen et al., 2009), the a1 helix is partially or completely
unwound, potentially allowing direct contacts between some of
the residues implicated in our study and gp41. In applying these
observations to the unliganded Env gp complex, however, two
caveats should be kept in mind. First, in all prior studies,
gp120 inner-domain components were deleted or modified to
promote crystallization. Second, in light of the possibility that
the inner domain interacts with gp41, structures of this region
that are relevant to the unliganded Env gp trimer may require
the inclusion of gp41 components.
Changes in the layer 1-layer 2 interface apparently decrease
the spontaneous sampling of the CD4-bound conformation by
HIV-1 gp120, lowering the on-rate binding affinity and neutralization potency of CD4i antibodies (Table 2 and Figure S1; Kassa
et al., 2009). CCR5 binding is also sensitive to these layer 1-layer
2 changes. By contrast, the initial contact of CD4 with gp120,
reflected in its on rate, is minimally affected by inner-domain
changes and, thus, appears not to depend upon the sampling
of the CD4-bound conformation by gp120 (Zhou et al., 2007;
Rits-Volloch et al., 2006). Rather, changes in the integrity of the
layer 1-layer 2 interface influence the off rate of the CD4-gp120
complex; this effect cannot be explained by direct contacts of
layer 1 or layer 2 residues with CD4 (Pancera et al., 2010). The
S375W change, which fills the Phe 43 cavity, completely compensates for the inability of inner-domain mutants to decrease
the off rate of bound CD4; however, in the absence of CD4,
the S375W change is not sufficient to allow spontaneous
sampling of the conformation required for efficient recognition
by CCR5 and CD4i antibodies. Thus, layers 1 and 2 in the inner
domain contribute to the ability of gp120 to make the transition
from the unliganded to the CD4-bound state; subtle differences
exist in the requirements for binding CD4 on the one hand and
CD4i antibodies/CCR5 on the other.
Alteration of gp120 residues in the layer 1-layer 2 interface
(H66A, W69L, L111A, and P212A) resulted in increased resistance to neutralization by sCD4. Differences in the affinity of
monomeric gp120 for CD4 likely contribute to the sCD4 resistance of these mutants (Figure S3), as has been observed for
other HIV-1 Env gp variants with decreases in CD4 binding (Thali
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et al., 1991). Consistent with this, the S375W change restored
the CD4-binding affinity of the H66A, W69L, and L111A mutants
and reverted the phenotypes of resistance to both sCD4 neutralization and sCD4 induction of gp120 shedding. Of interest,
changes in the a0 helix of layer 1 have been reported to segregate with sCD4 resistance during the passage of a primary
HIV-1 isolate in a T cell line (Orloff et al., 1995).
Soluble CD4 induces an activated state in the HIV-1 Env gps
that rapidly decays into functionally inactive forms (Haim et al.,
2009). Alterations in layer 1 (e.g., H66A and W69L) apparently
affect this decay process, even when sCD4 binding to the Env
gps is restored by the S375W change in the Phe 43 cavity. During
infection of CD4-negative, CCR5-positive target cells, viruses
with the H66A/S375W and W69L/S375W mutant Env gps were
activated at low sCD4 concentrations. During infection of CD4expressing target cells, these mutant viruses were neutralized
as efficiently by sCD4 as viruses with wild-type Env gps. Soluble
CD4-induced shedding of gp120 was comparable for the wildtype, H66A/S375W, and W69L/S375W Env gps. Therefore, the
H66A/S375W and W69L/S375W Env gps apparently bind sCD4
efficiently; nonetheless, these mutants demonstrate activation at
high sCD4 concentrations that, in parallel, do not activate wildtype HIV-1. In this respect, these HIV-1 mutants resemble SIV
(Allan et al., 1990; Schenten et al., 1999). Thus, the H66A and
W69L changes stabilize the sCD4-activated HIV-1 Env gp intermediate, slowing its decay into functionally inactive forms. The
observed correlation between the longevity of the sCD4-activated state and the duration of sCD4-induced exposure of the
gp41 HR1 region (Haim et al., 2009) is consistent with a role of
layer 1 in modulating conformational transitions in gp41. That
H66A/S375W and W69L/S375W Env gps differ from wild-type
Env gps in sCD4-induced activation decay, but not in gp120
shedding, underscores previous suggestions that the functionally inactive products of these two processes are distinct
(Si et al., 2004; Haim et al., 2009).
The involvement of layer 1 and layer 2 residues in gp41 association and in CD4 binding suggests a model for the unliganded
gp120 in the assembled Env gp trimer and for the conformational
switch that occurs upon CD4 binding (Figure 5). According to this
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studied herein exhibited wild-type levels of subunit association.
Thus, though both immunodeficiency virus lineages preserve
the potential to form a network of inner-domain interactions,
lineage-specific differences exist, probably driven by distinct
biological necessities.
EXPERIMENTAL PROCEDURES
Cell Lines
293T, Cf2Th, and TZM-bl cells were propagated as described in the Supplemental Information.

Figure 5. A Model of the Activation of the HIV-1 Env gps Triggered
by Binding to the CD4 Receptor
One of the three subunits of the HIV-1 Env gp trimer is depicted, oriented so
that the viral membrane is at the top of the figure. The gp41 ectodomain is
colored orange; the gp120 N and C termini, cyan; the b sandwich, red; layer
1, magenta; layer 2, green; layer 3, yellow; outer domain (OD), yellow; and
the b20-b21 loop, blue. In the unliganded state (left), layer 1 and layer 2 assume
conformations different from that observed in the CD4-bound state (Pancera
et al., 2010), allowing both layers to interact with the gp41 ectodomain. CD4
binding results in the apposition of layer 1 and layer 2 (right). This rearrangement of the gp120 inner domain slows the off rate of CD4 and allows the
gp41 ectodomain to undergo additional conformational changes necessary
for HIV-1 entry.

model, in the unliganded state, layer 2 interacts with the gp41
ectodomain. By virtue of its own interaction with gp41, layer 1
is shifted from its CD4-bound conformation, thus enhancing
the opportunity for layer 2 to contact gp41. The binding of CD4
to the wild-type HIV-1 Env gps results in the apposition of layer
1 and layer 2, as seen in the recent Pancera et al. crystal structure (Figures 1A and 1B). The layer 1-layer 2 interaction reduces
the off rate of the bound CD4. The layer 1-layer 2 interaction also
allows the gp41 ectodomain segment to undergo additional
conformational changes involved in virus entry; this process
may involve both the liberation of gp41 ectodomain segments
through the loss of previous interactions with layer 1 and layer
2 residues and the creation of new bonds between gp120 and
gp41 that favor the formation of the prehairpin intermediate.
This model helps to explain the relative lability of the sCD4bound state (Haim et al., 2009; Kassa et al., 2009). Altered
gp41 interactions with layers 1 and 2 resulting from sCD4 binding
might destabilize the gp41 ectodomain and either prematurely
promote conformational changes related to those involved in
virus entry or predispose to off-pathway inactivating events.
Future studies will test the specific predictions of this model.
The inner-domain residues implicated in the CD4-induced
conformational transition are well conserved within the HIV-1
and SIVcpz lineage (Figure S4). Of interest, the corresponding
residues are also conserved within the HIV-2/SIVsm lineage,
although differences between the HIV-1/SIVcpz and HIV-2/
SIVsm lineages are evident. For example, residue 375 is naturally
a tryptophan in the HIV-2/SIVsm viruses (Kuiken et al., 2008); in
HIV-1, substitution of tryptophan for serine 375 fills the Phe 43
cavity and diminishes the impact of alterations in layers 1 and
2 on CD4 binding. Alanine substitutions in the distal part of layer
2 (residues 206–214) in SIV gp120 have been previously reported
to decrease gp41 association (Rits-Volloch et al., 2006); however, two equivalent HIV-1 gp120 mutants (F210A and P212A)

Site-Directed Mutagenesis
Mutations were introduced into the pSVIIIenv plasmid expressing the fulllength HIV-1YU2 Env gps using the QuikChange II XL site-directed mutagenesis
protocol (Stratagene). The presence of the desired mutations was confirmed
by DNA sequencing. All residues are numbered according to those of the
prototypic HXBc2 sequence, as per current convention (Korber et al., 1998).
Ligand Binding of gp120
The ability of mutant gp120 to bind CD4-Ig, monoclonal antibodies, and CCR5
was assessed by immunoprecipitation or surface plasmon resonance biosensor analysis, as previously described (Johnsson et al., 1991). Detailed
descriptions can be found in the Supplemental Information.
Infectivity and Neutralization Assays
The infectivity and neutralization sensitivity of single-round luciferase-expressing HIV-1 were assessed as described (Madani et al., 2008; Thali et al., 1991)
and in the Supplemental Information.
Intramolecular Interactions
LIGPLOT (Wallace et al., 1995) was used to predict the hydrophobic interactions and hydrogen bonds between gp120 residues.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
doi:10.1016/j.molcel.2010.02.012.
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